ATLAS CAPITAL ADVISORS INC.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1434165
JACKSON, WY
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,803
-$19,316 QoQ
Shares Held
60
-45.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,539
of 1,705 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $1,601,611 across 7 Biotechnology names. VRTX ranks #4 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
4,983 | $1,200,753 | |
| 2 | RPRX |
Royalty Pharma plc
|
5,727 | $321,112 | |
| 3 | INCY |
Incyte Corp
|
351 | $39,789 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
60 | $29,803 | |
| 5 | ARVN |
Arvinas, Inc.
|
655 | $5,443 | |
| 6 | NKTR |
Nektar Therapeutics
|
40 | $2,792 | |
| 7 | INSM |
INSMED Inc
|
18 | $1,919 |
All Filings in VRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,803 | 60 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $49,119 | 110 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $49,869 | 110 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $48,972 | 110 | Shares | Sole | 2025-08-12 | |
| 2022-12-31 | $46,782 | 162 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $48,063 | 166 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $46,213 | 164 | Shares | Sole | 2022-08-16 | |
| 2021-12-31 | $1,098 | 5 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $906 | 5 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,008 | 5 | Shares | Sole | 2021-07-30 | |
| No filing history on record for this holder in this stock. | ||||||